Faslodex® (Fulvestrant) Injection 500-mg Pack Now Available For The Treatment Of Meta

[News]

AstraZeneca (NYSE: AZN) has announced that FASLODEX 500mg packs are now available for physicians to order. FASLODEX 500 mg is approved for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy...

More... (http://mnt.to/f/3Ppt)